This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 4 min This content is machine translated Fibrosis (FIB)-4 score Screening at-risk patients for NAFLD Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease. The FIB-4 score can be used to identify at-risk patients with NAFLD and, if necessary, refer them…
View Post 3 min This content is machine translated Fatty liver disease New widespread disease NAFLD Model calculations suggest that the number of patients with cirrhosis, advanced fibrosis, or hepatocellular carcinoma (HCC) could double to triple in the next 10-15 years. Not least because of this,…
View Post 5 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) What does the current guideline say? Non-alcoholic fatty liver disease is the most common liver disease worldwide. The German S2k guideline, updated in 2022, recommends screening patients at risk. The proposed screening algorithm includes fibrosis assessment…
